SUVEN PHARMACEUTICALS
|
The Current P/S Ratio of SUVEN PHARMACEUTICALS is 6.66.
| Share Price | ₹356.9 | Apr 15,2026 |
| Market Cap | ₹13,655.0 Cr | |
| Sales-TTM | ₹2,051.5 Cr | TTM-Consolidated Results |
| Price/Sales | 6.66x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SUVEN PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹13,655.0 Cr] as on Apr 15,2026
(/) Sales [ ₹2,051.5 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 6.66x ]
Thus, for SUVEN PHARMACEUTICALS , the investors are currently willing to pay '6.66 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SUVEN PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of SUVEN PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of SUVEN PHARMACEUTICALS
PS Ratio Performance Analysis for SUVEN PHARMACEUTICALS
- SUVEN PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 14.89x.
- SUVEN PHARMACEUTICALS 's operated at median p/e ratio of 12.49x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SUVEN PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 24.66x.
- SUVEN PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 8.98x.
How does SUVEN PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SUVEN PHARMACEUTICALS | 2,051.5 | 6.66 | 13,655.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.17 | 407,083.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 15.90 | 163,971.0 |
| CIPLA LTD | 28,351.1 | 3.49 | 99,086.7 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.04 | 140,660.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 2.93 | 101,686.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.30 | 87,624.9 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.61 | 94,183.5 |
| LUPIN LTD | 26,150.5 | 4.09 | 106,943.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.41 | 79,889.3 |
| ABBOTT INDIA LTD | 6,824.1 | 8.09 | 55,184.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SUVEN PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.41x |
| Max industry PS | 15.90x |
| Median industry PS | 6.30x |
| Average industry PS | 6.52x |
You may also like the below Video Courses